HIF-1-regulated vasoactive systems are differentially involved in acute hypoxic stress responses of the developing brain of newborn mice and are not affected by levetiracetam

Brain Research

Volumn 1199, Issue , 2008, Pages 27-36

  Trollmann, Regina ^a,b   Schneider, Julia ^b   Keller, Stephan ^a   Strasser, Katja ^b   Wenzel, Dieter ^b   Rascher, Wolfgang ^b   Ogunshola, Omolara O ^a   Gassmann, Max ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Hypoxia inducible transcription factor 1; Neuroprotection; Nitric oxide synthase; Vascular endothelial growth factor

Indexed keywords

ETIRACETAM; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; OXYGEN; PROTEIN SUBUNIT; SODIUM CHLORIDE; VASCULOTROPIN;

ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN DEVELOPMENT; BRAIN INJURY; BRAIN ISCHEMIA; C57BL 6 MOUSE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EPILEPSY; GENE; GLIA CELL; HIF 1 GENE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MOUSE; NEUROPROTECTION; NEWBORN; NONHUMAN; OXYGEN SUPPLY; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; TRANSCRIPTION INITIATION; UPREGULATION; WESTERN BLOTTING;

MUS;

EID: 40049108004     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.12.069     Document Type: Article

References (42)

1. Bergeron M. Gidday J.M. Yu A.Y. Semenza G.L. Ferriero D.M. Sharp F.R. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain Ann. Neurol. 48 2000 285 296
2. Bernaudin M. Tang Y. Reilly M. Petit E. Sharp F.R. Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance J. Biol. Chem. 277 2002 39728 39738
3. Blumberg R.M. Taylor D.L. Yue X. Aguan K. McKenzie J. Cady E.B. Weiner C.P. Mehmet H. Edwards A.D. Increased nitric oxide synthesis is not involved in delayed cerebral energy failure following focal hypoxic–ischemic injury to the developing brain Pediatr. Res. 46 1999 224 231
4. Chavez J.C. LaManna J.C. Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor 1 J. Neurosci. 22 2002 8922 8931
5. Curristin S.M. Cao A. Stewart W.B. Zhang H. Madri J.A. Morrow J.S. Ment L.R. Disrupted synaptic development in the hypoxic newborn brain PNAS 99 2002 15729 15734
6. Doheny H.C. Ratnaraj N. Whittington M.A. Jefferys J.G. Patsalos P.N. Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (ucb L059) in the rat Epilepsy Res. 34 1999 161 168
7. Dobbing J. Sands J. Comparative aspects of the brain growth spurt Early Hum. Dev. 3 1979 79 83
8. Fandrey J. Gorr T.A. Gassmann M. Regulating cellular oxygen sensing by hydroxylation Cardiovasc. Res. 71 2006 642 651
9. Gibbs J.E. Walker M.C. Cock H.R. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus Epilepsia 47 2006 469 478
10. Gibbs J.E. Cock H.R. Administration of levetiracetam after prolonged status epilepticus does not protect from mitochondrial dysfunction in a rodent model Epilepsy Res. 73 2007 208 212
11. Grimm C. Hermann D.M. Bogdanova A. Hotop S. Kilic U. Wenzel A. Kilic E. Gassmann M. Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration Semin. Cell Dev. Biol. 16 2005 531 538
12. Golde S. Chandran S. Brown G.C. Compston A. Different pathways for iNOS-mediated toxicity in vitro dependent on neuronal maturation and NMDA receptor expression J. Neurochem. 82 2002 269 282
13. Gonzalez-Barrios J.A. Escalante B. Valdes J. Leon-Chavez B.A. Martinez-Fong D. Nitric oxide and nitric oxide synthases in the fetal cerebral cortex of rats following transient uteroplacental ischemia Brain Res. 945 2002 114 132
14. Gower A.J. Noyer M. Verloes R. Gobert J. Wulfert E. Ucb L059, a novel anti-convulsant drug: pharmacological profile in animals Eur. J. Pharmacol. 222 1992 193 203
15. Gu J. Lynch B.A. Anderson D. Klitgaard H. Lu S. Elashoff M. Ebert U. Potschka H. Löscher W. The antiepileptic drug levetiracetam selectively modifies kindling-induced alterations in gene expression in the temporal lobe of rats Eur. J. Neurosci. 19 2004 334 345
16. Gustavsson M. Mallard C. Vannucci S.J. Wilson M.A. Johnston M.V. Hagberg H. Vascular response to hypoxic preconditioning in the immature brain J. Cereb. Blood Flow Metab. 27 2006 928 938
17. Hanon E. Klitgaard H. Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia Seizure 10 2001 287 293
18. Helton R. Cui J. Scheel J.R. Ellison J.A. Ames C. Gibson C. Blouw B. Ouyang L. Dragatsis I. Zeitlin S. Johnson R.S. Lipton S.A. Barlow C. Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage J. Neurosci. 25 2005 4099 4107
19. Janz R. Goda Y. Geppert M. Missler M. Sudhof T. SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release Neuron 24 2003 1003 1016
20. Jensen E.J. Developmental factors regulating susceptibility to perinatal brain injury and seizures Curr. Opin. Pediatr. 18 2006 628 633
21. Jin K. Zhu Y. Sun Y. Mao X.O. Xie L. Greenberg D.A. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo Proc. Natl. Acad. Sci. U. S. A. 99 2002 11946 11950
22. Johnston M.V. Selective vulnerability in the neonatal brain Ann. Neurol. 44 1998 155 156
23. Katz I. Kim J. Gale K. Kondratyev A. Effects of lamotrigine alone and in combination with MK-801, phenobarbital or phenytoin on cell death in the neonatal rat brain J. Pharmacol. Exp. Ther. 322 2007 494 500
24. Kaur C. Sivakumar V. Ang L.S. Sundaresan A. Hypoxic damage to the periventricular white matter in neonatal brain: role of vascular endothelial growth factor, nitric oxide and excitotoxicity J. Neurochem. 98 2006 1200 1216
25. Löscher W. Hönack D. Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy J. Pharmacol. Exp. Ther. 284 1998 474 479
26. Lynch B.A. Lambeng N. Nocka K. Kensel-Hammes P. Bajjalieh S.M. Matagne A. Fuks B. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam Proc. Natl. Acad. Sci. U. S. A. 101 2004 9861 9866
27. Marini H. Costa C. Passaniti M. Esposito M. Campo G.M. Ientile R. Adamo E.B. Marini R. Calabresi P. Altavilla D. Minutoli L. Pisani F. Squadrito F. Levetiracetam protects against kainic acid-induced toxicity Life Sci. 74 2004 1253 1264
28. Manthey D. Asimiadou S. Stefovska V. Kaindl A.M. Fassbender J. Ikonomidou C. Bittigau P. Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain Exp. Neurol. 193 2005 497 503
29. Mooney S.M. Miller M.W. Expression of bcl-2, bax, and caspase-3 in the brain of the developing rat Brain Res. Dev. Brain Res. 123 2000 103 117
30. Muramatsu K. Sheldon R.A. Black S.M. Tauber M. Ferriero D.M. Nitric oxide synthase activity and inhibition after neonatal hypoxia ischemia in the mouse brain Brain Res. Dev. Brain Res. 123 2000 119 127
31. Ogunshola O.O. Antic A. Donoghue M.J. Fan S.Y. Kim H. Stewart W.B. Madri J.A. Ment L.R. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system J. Biol. Chem. 277 2002 11410 11415
32. Pannu R. Singh I. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms Neurochem. Int. 49 2006 170 182
33. Potschka H. Baltes S. Loscher W. Inhibition of multidrug transporters by verapamil or probenecid does not alter blood–brain barrier penetration of levetiracetam in rats Epilepsy Res. 58 2004 85 91
34. Shao G. Gao C.Y. Lu G.W. Alterations of hypoxia-inducible factor-1 alpha in the hippocampus of mice acutely and repeatedly exposed to hypoxia Neurosignals 14 2005 255 261
35. Siddiq A. Ayoub I.A. Chavez J.C. Aminova L. Shah S. LaManna J.C. Patton S.M. Connor J.R. Cherny R.A. Volitakis I. Bush A.I. Langsetmo I. Seeley T. Gunzler V. Ratan R.R. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system J. Biol. Chem. 280 2005 41732 41743
36. Stroka D.M. Burkhardt T. Desbaillets I. Wenger R.H. Neil D.A.H. Bauer C. Gassmann M. Candinas D. HIF-1 is expressed in normoxic tissues and displays an organ-specific regulation under systemic hypoxia FASEB. J. 15 2001 2445 2453
37. van den Tweel E.R. Nijboer C. Kavelaars A. Heijnen C.J. Groenendaal F. van Bel F. Expression of nitric oxide synthase isoforms and nitrotyrosine formation after hypoxia–ischemia in the neonatal rat brain J. Neuroimmunol. 167 2005 64 71
38. Trollmann R. Amann K. Schoof E. Beinder E. Wenzel D. Rascher W. Dötsch J. Hypoxia activates human placental VEGF system in vitro and in vivo: up-regulation of placental VEGF system in clinically relevant hypoxic ischemia in birth asphyxia Am. J. Obstet. Gynecol. 188 2003 517 523
39. Witt K.A. Mark K.S. Huber J. Davis T.P. Hypoxia-inducible factor and nuclear factor kappa-B activation in blood–brain barrier endothelium under hypoxic/reoxygenation stress J. Neurochem. 92 2005 203 214
40. Woodward L.J. Anderson P.J. Austin N.C. Howard K. Inder T.E. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants N. Engl. J. Med. 355 2006 685 694
41. Zhao P. Zuo Z. Prenatal hypoxia-induced adaptation and neuroprotection that is inducible nitric oxide synthase-dependent Neurobiol. Dis. 20 2005 871 880
42. Zhu Y. Jin K. Mao X.O. Greenberg D.A. Vascular endothelial growth factor promotes proliferation of cortical neuron precursors by regulating E2F expression FASEB. J. 17 2003 186 193